Antronette McKenzie, MD
Family Medicine · Southaven, MSNPI 1336146315
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $525 and has fallen 75.7% since, to $128 in 2024.
Across 98 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$398
- AstraZeneca$268
- Novo Nordisk$242
- Amarin Pharma, Inc.$218
- Bayer$174
- Boston Scientific$174
- plus $494 from 13 others
What the payments were for
- Food & beverage$1,968100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $398 |
| AstraZeneca | 10 | $268 |
| Novo Nordisk | 15 | $242 |
| Amarin Pharma, Inc. | 10 | $218 |
| Bayer | 5 | $174 |
| Boston Scientific | 4 | $174 |
| Boehringer Ingelheim | 9 | $142 |
| Pfizer | 6 | $96 |
| Esperion Therapeutics, Inc. | 3 | $47 |
| AbbVie(2 entities) | 3 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Scynexis, Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $15 |
| Shield Therapeutics Inc | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Merck | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,968 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 88 | $455 |
| Amlodipine Besylate | 104 | $432 |
| Rosuvastatin Calcium | 50 | $402 |
| Omeprazole | 34 | $329 |
| Fluticasone Propionate | 31 | $328 |
| Levothyroxine Sodium | 35 | $299 |
| Pravastatin Sodium | 18 | $245 |
| Losartan Potassium | 31 | $242 |
| Montelukast Sodium | 22 | $237 |
| Pantoprazole Sodium | 20 | $222 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 30 | $208 |
| Ezetimibe | 15 | $202 |
| Simvastatin | 48 | $202 |
| Escitalopram Oxalate | 20 | $199 |
| Lisinopril | 27 | $197 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Southaven
- Walter CarnahanSouthaven$146K
- Robert SkinnerSouthaven$9K
- Russell CarlisleWesson$1.6M
- Keith StokesLexington$654K
- Karen WhitneyWhitfield$117K
- Dava ClevelandJackson$100K
- Andrea PhillipsJackson$96K
- Kristi TrimmRidgeland$34K
- Tana CooperBiloxi$25K
- Delora DenneyPicayune$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.